---
title: "Nuvectis Pharma Sets 5M-Share, $20 Offering; ~$93M Net, Cantor Fitzgerald Underwriter"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291334045.md"
description: "Nuvectis Pharma has entered into an underwriting agreement with Cantor Fitzgerald for a firm-commitment public offering of 5 million shares at $20 per share. The deal includes a 30-day option to purchase up to 750,000 additional shares. Expected to close on July 1, 2026, the offering aims to raise approximately $93 million in net proceeds, or $107 million if the over-allotment is exercised, to fund operations and development programs."
datetime: "2026-06-30T20:53:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291334045.md)
  - [en](https://longbridge.com/en/news/291334045.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291334045.md)
generator: "portal-rs"
---

# Nuvectis Pharma Sets 5M-Share, $20 Offering; ~$93M Net, Cantor Fitzgerald Underwriter

Nuvectis Pharma entered into an underwriting agreement with Cantor Fitzgerald for a firm-commitment public offering of 5,000,000 shares of common stock at $20.00 per share. The underwriters have a 30-day option to purchase up to 750,000 additional shares. The offering is expected to close on Jul 1, 2026, generating approximately $93 million in net proceeds, or about $107 million if the option is exercised.

**Agreement details:**

-   **Agreement type**: Underwriting agreement for firm-commitment public offering of common stock
-   **Counterparty**: Cantor Fitzgerald
-   **Signed / Effective**: Jun 29 2026 / same
-   **Duration / Termination**: Until closing (expected Jul 01 2026)
-   **Reason**: Raise capital to fund operations and development programs

Original SEC Filing: Nuvectis Pharma, Inc. \[ NVCT \] - 8-K - Jun. 30, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [NVCT.US](https://longbridge.com/en/quote/NVCT.US.md)

## Related News & Research

- [Nuvectis Pharma to present at H.C. Wainwright annual investment conference](https://longbridge.com/en/news/297909736.md)
- [Some of the Top Biotech Funds Just Bought Into This Under-the-Radar Biotech (NASDAQ: NVCT)](https://longbridge.com/en/news/297912026.md)
- [Quanta Services announces dividend of R$ 0.03 per unit for Q3 2026](https://longbridge.com/en/news/297931955.md)
- [Marisa updates financial events calendar for 2026](https://longbridge.com/en/news/297913424.md)
- [Pininfarina announces availability of H1 2026 interim financial report](https://longbridge.com/en/news/298044460.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**